I think I'll have an alpha/beta testing period with interested volunteers. Then hopefully sell it. Then after some years and waning interest, probably open source it.
I am making a game. I use Vim (infinitely faster and more product than other text editors) and write a single command in my terminal to compile. Vim makes a lot of sense when you want to work fast and don't want bloated development toolchains to slow you down. There's nothing in modern IDEs that would increase my productivity that I can't add to Vim in about 5-20 minutes.
None of those criticisms apply to these vaccine studies. There are many issues that can arise in trials, of course. But the current batch of 3-phase mRNA-based vaccine trials have all been intensely scrutinized at every turn. I think it will be difficult for you to argue otherwise, but feel free to enlighten us about the data corruption conspiracy if you have some evidence.
No. The onus is on you to explain why experts who have devoted their entire lives to groundbreaking vaccine research are wrong. It's like arguing with a 5 year old.
I'm not going to explain how clinical trials work and why you should trust that process. Again, bad situations do not invalidate all work being done in a field.
"So much faith"? People are just following the science. Are you really arguing that because one bad situation has occurred involving pharmaceutical companies, we should assume every new drug or treatment is bogus or based on evil motives?
This is a common sentiment that fails to take into account the fact that, once you DO exist, you have a desire to continue existing which you did not have prior to your existence.
Sure, but you have to balance the potential bad with the fact that humans have an inborn drive to continue existing, and that death has profoundly negative effects that induce unnecessary suffering. If Jeff Bezos was your son and he was afflicted with a terminal disease, you'd have a very different outlook on his potential death, no matter what views you held at a high level societal perspective.